A proposed order would move immunohistochemistry tests tied to approved cancer drugs from class III to class II, swapping premarket approval for 510(k) clearance plus special controls. Comments close 11 January 2027.
4 min read
A final order published 5 November creates a device category for digital cervical cytology imaging systems with AI, letting future versions clear through the 510(k) route instead of the strictest class III review.
3 min read
ANALYSISA CMS and CDC proposed rule would codify pandemic-era remote review of digital lab data, allow digital images in gynaecologic cytology proficiency testing, and ease 2024 staffing rules. Comments close 7 December.
3 min read
WHAT THE STUDY ACTUALLY SAYSTwo 2026 studies posted high accuracy for AI reading Pap-smear cells and colposcopy images in settings short of pathologists. Both were validated internally, which is where such numbers usually shrink.
3 min read
A review of Paige Prostate Detect and Ibex Prostate Detect finds the tools mainly help less-specialized pathologists, and warns performance shifts when a tool meets a new population.
3 min read